PHVS Pharvaris NV Total Asset Value of Company
Pharvaris N.V. (PHVS) attracts leading biochemists through unique R&D projects and stock options while fostering an ethical corporate culture. Simultaneously, the company is implementing energy-efficient systems and closed-loop water recycling to comply with ESG standards. The price action of exchange-traded quotes for total assets is recorded at 311.00. Growth prospects are based on the patenting of a high-margin oral treatment for hereditary angioedema, which strengthens the issuer's market position.
Analytical breakdowns and data insights for company Pharvaris Corp (PHVS)
- current quotes and average value forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Pharvaris N.V.|PHVS - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Pharvaris Pharma|PHVS - Company Aggregate Debts|Debts to Book Capitalization Pharvaris Pharma|PHVS - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Pharvaris|Interim Coverage Ratio pharvaris.com
- net income and valuation multiples indicators:
Fundamental valuation:Pharvaris N.V.
This indicator represents a reverse calculation of total assets and liabilities via return on assets, which allows for the stripping of market volatility from the company's fundamental basis. The trend in projected assets and resources reflects the efficiency of innovation capitalization at Pharvaris N.V. (PHVS), where the growth of this metric confirms the scaling of production for unique oral medications used in the therapy of hereditary angioedema.
Key competitors
ARGX - Company Total Asset Base|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|ABCL (AbCellera Biologics) - Aggregate Asset Value|Company Total Assets TRML (Tourmaline Corp)|Company Total Asset Base Precigen Corp (PGEN)|PHAR - Aggregate Company Assets|nektar.com (NKTR) - Cumulative Company Assets|Upstream Bio (UPB) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|Cumulative Company Assets IMNM|Company Total Assets Gossamer Bio Corp.|Aggregate Company Assets KalVista Pharmaceuticals (KALV)|septerna.com - Total Business Assets|Company Total Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Company Assets|RIGL - Aggregate Company Assets|Total Asset Value of Company ANAB|ATXS: Company Total Assets|engene.com - Aggregate Asset Value|RAPT (RAPT Therapeutics) - Company Total Assets|Company Total Assets Aerovate|Aggregate Company Assets Aclaris (ACRS)|KYTX (Kyverna Therapeutics, Inc) - Aggregate Asset Value|Tiziana Life Sciences - Cumulative Company Assets|cabalettabio.com - Aggregate Company Assets|Ventyx Biosciences, Inc. - Company Total Assets|THTX - Company Total Assets|Avalo Therapeutics Inc. (AVTX) - Aggregate Company Assets|Eledon Pharmaceuticals, Inc - Aggregate Asset Value|AGEN (Agenus) - Company Total Assets|climbbio.com (CLYM) - Company Total Asset Base|Aggregate Company Assets Zura Bio (ZURA)|Company Total Asset Base aTyr Pharma Inc|Adagene Inc. - Cumulative Company Assets|Aggregate Asset Value IMA|STTK - Aggregate Company Assets|EQ (Equillium, Inc.) - Total Business Assets|CNTB (connectbiopharm.com) - Cumulative Company Assets|IMUX - Company Total Asset Base|Cumulative Company Assets ATRA|Aggregate Company Assets IFRX|Cumulative Company Assets XFOR (X4 Pharmaceuticals)|Company Total Asset Base adicetbio.com|Aggregate Company Assets Celularity CELU|INMB (INmune Bio Inc) - Total Asset Value of Company|Barinthus Bio - Company Total Assets|Aggregate Asset Value KZR (Kezar Life Sciences Inc)|SABS (SAB Biotherapeutics) - Cumulative Company Assets|AKTX (akaritx.com) - Aggregate Company Assets|Aggregate Company Assets Enlivex Therapeutics Ltd|Q32 Bio Corp (QTTB) - Company Total Asset Base|Aggregate Company Assets GeoVax Labs Inc (GOVX)|EDSA: Total Asset Value of Company|Company Total Assets IBIO (iBio, Inc.)|Aggregate Asset Value CARM|XTL Biopharmaceuticals Ltd. - Company Total Assets|BOLT - Company Total Assets|hcwbiologics.com (HCWB) - Aggregate Company Assets|Aptevo Therapeutics Inc. - Aggregate Asset Value|Aggregate Company Assets AIM ImmunoTech Inc.|Cumulative Company Assets Aditxt Corp (ADTX)|Company Total Assets GRI|Company Total Assets XORTX Therapeutics Inc (XRTX)|ReShape Lifesciences - Cumulative Company Assets|Aggregate Asset Value REVB|Indaptus Therapeutics - Company Total Assets|Company Total Asset Base scinai.com SCNI|calcimedica.com (CALI) - Aggregate Company Assets|Cumulative Company Assets Affimed N.V.|Aggregate Company Assets Allakos Inc|Cumulative Company Assets HOOKIPA (HOOK)|Cumulative Company Assets IGMS (IGM Biosciences, Inc.)|Company Total Assets iteostherapeutics.com (ITOS)|Aggregate Company Assets Ocean Biomedical OCEA|TCBP: Total Business Assets|Third Harmonic Bio, Inc - Company Total Assets